Alzheimer’s patients and their families hear a new word: Progress
Two new drugs—including one from Indianapolis-based Eli Lilly—and better detection methods offer promise for people dealing with the disease.
Health Care & Insurance
Articles
Ascension St. Vincent set to open new $200M Women and Infants Hospital
Ascension St. Vincent provided a sneak peak Monday of its Women and Infants Hospital, a $200 million project with 30 maternity suites and 109 neonatal intensive care unit rooms.
Milton spares Florida factory that’s critical supplier of IV fluids
B. Braun Medical’s manufacturing site and distribution center in Daytona Beach were not seriously impacted by the hurricane, said a company spokesperson. The center produces about a quarter of the country’s IV fluids.
Indiana joins multistate lawsuit seeking to halt federal nursing home staffing rule
A lawsuit filed Tuesday by 20 states challenging a federal rule mandating higher staffing levels in nursing homes alleges that facilities will be forced to close.
Community Health planning major expansion of north side cancer center
The Indianapolis-based hospital system wants to add 34,645 square feet to its MD Anderson Cancer Center at 7979 Shadeland Ave., on the Community Hospital North campus.
Eskenazi Health lands $10M gift from Lilly Endowment for internships to college students with physical disabilities
The gift will fund operations at Gregory S. Fehribach Center at Eskenazi Health for the next five years and also create an endowment for future funding.
Carmel physician wins $2M from Ascension for breach of contract, interference
The jury deliberated for about three hours before returning a verdict in favor of Dr. Timothy Story, ending a lawsuit that lasted for about 3-1/2 years.
Marathon Health expands network to 720 locations
Growth has come chiefly from a series of mergers, including one earlier this year with Denver-based Everside Health.
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Lilly has been making the case since August that its tirzepatide-based drugs are now “commercially available,” which the FDA agreed on. But the agency warned that patients and prescribers might still experience “localized supply disruptions.”
Lilly to invest another $4.5B in Lebanon site for new ‘medicine foundry’
The new funding, for an advanced manufacturing and drug development center, will bring the Indianapolis-based drugmaker’s total investment in the Boone County site to more than $13 billion.
Roche has more than five weight-loss companion medicines, CEO says
The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co.
Elevance Health to make $11.9M expansion in Indianapolis, add 230 jobs
Elevance said it plans make its investment at two locations: its headquarters at 220 Virginia Avenue and another site at 4740 Victory Lane on the southeast side.
Braun health care plan builds on legislative action that previously failed
In contrast to Gov. Eric Holcomb, who largely stayed out of ongoing legislative negotiations, Braun firmly put his thumb on the scale in favor of one perspective over another across several contentious, ongoing discussions.
Weight-loss drugs are supposed to be forever … until they run out
Recurrent shortages, shifting insurance coverage, indecision and a lack of guidance about side effects and dosing have led to challenges for some patients prescribed Mounjaro, Ozempic, Zepbound or Wegovy.
Lilly seeks court ruling that could mean big money for new weight-loss drug
The Indianapolis-based drugmaker filed a suit in federal court this month, challenging the U.S. Food and Drug Administration’s ruling that the company’s experimental obesity treatment not a biological product.
Eli Lilly requests records of people who took copies of its weight-loss drug
The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell the compounded versions has intensified.
IU, Indiana Biosciences Research Institute partner on new personalized medicine center
The Joint Center of Excellence for Point of Care Precision Medicine aims to develop better personalized care for patients with diabetes, cancer, Alzheimer’s disease and pediatric rare disease.
Psychiatric hospital committed medical negligence, complaint alleges
A complaint filed last week with the Indiana Department of Insurance alleges gross violations of care at an Indianapolis behavioral health facility.
Walgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
The pharmacy chain was accused of submitting false payment claims to Medicare, Medicaid and other federal health care programs between 2009 and 2020 for prescriptions that were processed but never picked up.
Workers, employees likely to see another stiff increase in health benefits
Nationally, the average cost of employer-sponsored health plans is expected to grow 9% next year if companies don’t find ways to cut costs, according to an Aug. 15 report by professional services firm Aon.